Brief: Kancera Gives Operational Update Concerning Its Clinical Development Program

Novakand Pharma AB

23/08/2024 07:35

Aug 23 (Reuters) - Kancera AB  KANC.ST :
    * KANCERA GIVES AN OPERATIONAL UPDATE CONCERNING ITS
CLINICAL
DEVELOPMENT PROGRAM
    * PHASE IIA PART IN KANDOVA STUDY HAS BEEN INITIATED AND
STUDY
OBJECTIVES MAY BE MET WITH FEWER PATIENTS THAN INITIALLY PLANNED
    * PREVIOUSLY REPORTED POSITIVE TOP-LINE RESULTS FROM FRACTAL
STUDY
AND KAND145 PHASE I STUDY ARE SUPPORTED BY ADDITIONAL DETAILED
ANALYSES

Source text for Eikon:  ID:nMFN8gBTNM 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))